DRD2 and drug-induced dyskinesia: Polymorphisms of the dopamine D2 receptor and transporter gene, as well as the TaqIA polymorphism located in the gene encoding the D2 receptor, have been shown to be associated with the risk of developing dyskinesias in PD [36, 37].